This is the recording of the regular press briefing of European Medicines Agency on COVID-19 vaccines and therapeutics that took place on 9 September 2021.
00:00 Introduction
02:02 Update on recent developments (as of 04.11.2021) by Dr. Cavaleri
10:40 Questions from journalists
11:04 What are the tools to tackle the pandemic
13:43 Fourth dose of COVID-19 vaccine
18:38 Mix and match approach
21:36 Antiviral therapies
23:43 Data on AstraZeneca
25:13 Children vaccination
30:00 BMJ report
32:15 Monoclonal antibodies
34:46 Pregnant women
36:16 Vaxveria vaccine
39:20 Molnupiravir and Fluvoxamine
41:19 Wrap-up
EMA Speakers:
Marco Cavaleri, Head of Biological Health Threats and Vaccines Strategy
Fergus Sweeney, Head of Clinical Studies and Manufacturing Task Force
Georgy Genov, Head of Pharmacovigilance
EMA Moderator:
Marie-Agnes Heine, Head of Communication
#EMAPresser #COVID19
